Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, September 22, 2022
Kaléo announced the execution of the first contract with the U.S. Department of Defense (DoD) for the procurement of the Rapid Opioid Countermeasure System (ROCS), a 10 mg Naloxone Auto-injector (naloxone hydrochloride injection) antidote for ultra-...
read more
Tuesday, September 12, 2017
Kaneka Eurogentec announced its board has approved the construction of a new state of-the-art GMP facility adjacent to its current facility and equipped with a 2200 L fermenter.
read more
Tuesday, November 29, 2022
Kaneka Corporation will manufacture and supply intermediates to Shionogi & Co., Ltd. for use in Xocova® (Ensitrelvir Fumaric Acid) Tablets 125mg, a drug for the treatment of SARS-Cov-2 infection.
read more
Tuesday, November 05, 2024
Kashiv BioSciences announced the appointment of Dr. Sandeep Nilkanth Athalye as Global Chief Executive Officer. Dr. Athalye, a seasoned leader with over two decades of experience in strategic and operational roles within the global pharmaceutical ...
read more
Tuesday, January 10, 2023
Kayentis and ClinOne announced a strategic alliance. This collaboration combines Kayentis’ expertise in clinical trial data collection with ClinOne’s best-in-class consent management and patient engagement technology.
read more
Kayentis announces it is moving ahead on five new eCOA service projects with Emerging BioPharma (EBP) companies.
read more
Wednesday, March 23, 2022
Kayentis has announced the launch of a fully integrated patient-centric platform that optimizes the management of hybrid and Decentralized Clinical Trials (DCT).
read more
Thursday, November 14, 2019
Kayentis has announced the opening of a subsidiary in Japan, the world’s third largest pharmaceutical market.
read more
KBI Biopharma, Inc. (KBI) has signed an agreement with Merck & Co., Inc. (known as Merck in the United States and Canada) to acquire Merck’s microbial process development and manufacturing operations in Boulder, Colorado, effective May 1, 2014. Under...
read more
KBI Biopharma has completed the acquisition of the assets of Elion Labs, a contract services organization in Louisville, CO.
read more
KBI Biopharma Inc., a JSR Life Sciences company, and AM-Pharma, an emerging leader focused on the development of therapeutics that protect organ function in patients with severe medical conditions, have signed a commercial manufacturing agreement to ...
read more
Monday, December 03, 2018
KBI Biopharma and Selexis have appointed four leading, internationally recognized scientists to their newly formed Joint Scientific Advisory Board (JSAB).
read more
KBI Biopharma and Selexis SA, both JSR Life Sciences companies, announced the appointment of J.D. Mowery as Chief Executive Officer (CEO).
read more
KBI Biopharma SA (KBI) and Selexis SA, both JSR Life Sciences companies, announced that an expanded, fully-integrated mammalian contract development and manufacturing services facility is now open and operational in Geneva, Switzerland.
read more
Tuesday, December 03, 2024
KBI Biopharma, Inc. announced a manufacturing contract with Alanis Therapeutics, Inc. (ATI) for the development of an innovative pre-clinical therapeutic antibody to treat myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) blood cancers...
read more